Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05026697 · ClinicalTrials.gov registry record

Validity and Reliability of Commercially Available Bioelectrical Impedance Analysis Devices

A clinical trial of Body Composition, sponsored by Texas Tech University.

Completed
Registry status
75
Enrollment target
1
Study location

NCT05026697: Completed study of Body Composition, sponsored by Texas Tech University.

NCT05026697 is a study of Body Composition that has completed, run by Texas Tech University. The registered enrollment target is 75 participants, below the 113-participant average among 20 other Body Composition trials with a reported enrollment target (34% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05026697, a study of Body Composition, has completed, sponsored by Texas Tech University.

COMPLETED
Registry status
75 participants
Enrollment target
1
Study location

Study Summary

The purpose of this data collection is to establish the validity and reliability of several different commercially available bioelectrical impedance analysis devices that are used to estimate body composition.

Primary Outcome

Percentage of body mass that is attributable to fat mass. This value is provided by each body composition assessment device being tested (see list of devices in Study Description).

Conditions Studied

Study Locations (1)

Texas

  • Department of Kinesiology & Sport Management - Lubbock

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2021-06-09
Est. Completion 2021-12-10
Texas Tech University

69 total trials

What the finished NCT05026697 record still lists

NCT05026697 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 113-participant average among 20 other Body Composition trials with a reported enrollment target (34% lower).

The record links to 1 condition, with Body Composition appearing as the primary indexed condition, and to 0 interventions.

NCT05026697 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT05026697 about?

NCT05026697 is a clinical study titled "Validity and Reliability of Commercially Available Bioelectrical Impedance Analysis Devices". The purpose of this data collection is to establish the validity and reliability of several different commercially available bioelectrical impedance analysis devices that are used to estimate body composition.

What is the current status of trial NCT05026697?

This trial is currently completed. The enrollment target is 75 participants. The study started on 2021-06-09. Estimated completion is 2021-12-10.

What conditions does trial NCT05026697 study?

This clinical trial studies the following conditions: Body Composition.

Who is sponsoring clinical trial NCT05026697?

This trial is sponsored by Texas Tech University, which has 69 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05026697 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Body Composition

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05026697's enrollment target sits among peer trials

75 10th of 20 higher than 10 of 20 other Body Composition trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Body Composition trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05026697, the US trial registry maintained by the National Library of Medicine. NCT05026697 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.